These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27105923)

  • 1. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.
    Sims DJ; Harrington RD; Polley EC; Forbes TD; Mehaffey MG; McGregor PM; Camalier CE; Harper KN; Bouk CH; Das B; Conley BA; Doroshow JH; Williams PM; Lih CJ
    J Mol Diagn; 2016 May; 18(3):336-349. PubMed ID: 27105923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic comparison of germline variant calling pipelines cross multiple next-generation sequencers.
    Chen J; Li X; Zhong H; Meng Y; Du H
    Sci Rep; 2019 Jun; 9(1):9345. PubMed ID: 31249349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.
    Lih CJ; Harrington RD; Sims DJ; Harper KN; Bouk CH; Datta V; Yau J; Singh RR; Routbort MJ; Luthra R; Patel KP; Mantha GS; Krishnamurthy S; Ronski K; Walther Z; Finberg KE; Canosa S; Robinson H; Raymond A; Le LP; McShane LM; Polley EC; Conley BA; Doroshow JH; Iafrate AJ; Sklar JL; Hamilton SR; Williams PM
    J Mol Diagn; 2017 Mar; 19(2):313-327. PubMed ID: 28188106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
    Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
    J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Whole Mitochondrial Genome Sequencing with Short Overlapping Amplicons Suitable for Degraded DNA Using the Ion Torrent Personal Genome Machine.
    Chaitanya L; Ralf A; van Oven M; Kupiec T; Chang J; Lagacé R; Kayser M
    Hum Mutat; 2015 Dec; 36(12):1236-47. PubMed ID: 26387877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACMG clinical laboratory standards for next-generation sequencing.
    Rehm HL; Bale SJ; Bayrak-Toydemir P; Berg JS; Brown KK; Deignan JL; Friez MJ; Funke BH; Hegde MR; Lyon E;
    Genet Med; 2013 Sep; 15(9):733-47. PubMed ID: 23887774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample Tracking Using Unique Sequence Controls.
    Moore RA; Zeng T; Docking TR; Bosdet I; Butterfield YS; Munro S; Li I; Swanson L; Starks ER; Tse K; Mungall AJ; Holt RA; Karsan A
    J Mol Diagn; 2020 Feb; 22(2):141-146. PubMed ID: 31837431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized decision support in next generation sequencing reports of somatic cancer variants.
    Dienstmann R; Dong F; Borger D; Dias-Santagata D; Ellisen LW; Le LP; Iafrate AJ
    Mol Oncol; 2014 Jul; 8(5):859-73. PubMed ID: 24768039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA.
    de Boer EN; van der Wouden PE; Johansson LF; van Diemen CC; Haisma HJ
    Gene Ther; 2019 Aug; 26(7-8):338-346. PubMed ID: 31296934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.
    Davies KD; Farooqi MS; Gruidl M; Hill CE; Woolworth-Hirschhorn J; Jones H; Jones KL; Magliocco A; Mitui M; O'Neill PH; O'Rourke R; Patel NM; Qin D; Ramos E; Rossi MR; Schneider TM; Smith GH; Zhang L; Park JY; Aisner DL
    J Mol Diagn; 2016 Jul; 18(4):572-9. PubMed ID: 27155050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single-Nucleotide Variant Detection.
    Lee C; Bae JS; Ryu GH; Kim NKD; Park D; Chung J; Kyung S; Joung JG; Shin HT; Shin SH; Kim Y; Kim BS; Lee H; Kim KM; Kim JS; Park WY; Son DS
    J Mol Diagn; 2017 Sep; 19(5):651-658. PubMed ID: 28743024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Junction Location Identifier (JuLI): Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology.
    Shin HT; Kim NKD; Yun JW; Lee B; Kyung S; Lee KW; Ryu D; Kim J; Bae JS; Park D; Choi YL; Lee SH; Ahn MJ; Park K; Park WY
    J Mol Diagn; 2020 Mar; 22(3):304-318. PubMed ID: 31881333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive fundamental somatic variant calling and quality management strategies for human cancer genomes.
    He X; Chen S; Li R; Han X; He Z; Yuan D; Zhang S; Duan X; Niu B
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32510555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures.
    Mühr LSA; Guerendiain D; Cuschieri K; Sundström K
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices for variant calling in clinical sequencing.
    Koboldt DC
    Genome Med; 2020 Oct; 12(1):91. PubMed ID: 33106175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed Reference Materials as Controls for Diagnostic Next-Generation Sequencing: A Pilot Investigating Applications for Hypertrophic Cardiomyopathy.
    Kudalkar EM; Almontashiri NA; Huang C; Anekella B; Bowser M; Hynes E; Garlick R; Funke BH
    J Mol Diagn; 2016 Nov; 18(6):882-889. PubMed ID: 27639548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
    Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
    BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.